{"id":79337,"date":"2023-09-29T11:39:34","date_gmt":"2023-09-29T06:09:34","guid":{"rendered":"http:\/\/finservwealth.com\/novo-nordisk-india-head-eyes-2026-wegovy-launch-warns-against-copycats\/"},"modified":"2023-09-29T11:39:34","modified_gmt":"2023-09-29T06:09:34","slug":"novo-nordisk-india-head-eyes-2026-wegovy-launch-warns-against-copycats","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/novo-nordisk-india-head-eyes-2026-wegovy-launch-warns-against-copycats\/","title":{"rendered":"Novo Nordisk India head eyes 2026 Wegovy launch, warns against copycats"},"content":{"rendered":"<p> The market opportunity for the drug is huge in the world#39;s most populous country, where obesity rates are high especially among women. Illegal copycat versions of Wegovy are already being sold through online sites.<\/p><div id=\"finse-3402278531\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/novo-nordisk-india-head-eyes-2026-wegovy-launch-warns-against-copycats_17254981.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The market opportunity for the drug is huge in the world#39;s most populous country, where obesity rates are high especially among women. Illegal copycat versions of Wegovy are already being sold through online sites. The market opportunity for the drug is huge in the world#39;s most populous country, where obesity rates are high especially among women. Illegal copycat versions of Wegovy are already being sold through online sites.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/novo-nordisk-india-head-eyes-2026-wegovy-launch-warns-against-copycats_17254981.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The market opportunity for the drug is huge in the world#39;s most populous country, where obesity rates are high especially among women. Illegal copycat versions of Wegovy are already being sold through online sites.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/novo-nordisk-india-head-eyes-2026-wegovy-launch-warns-against-copycats_17254981.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The market opportunity for the drug is huge in the world#39;s most populous country, where obesity rates are high especially among women. Illegal copycat versions of Wegovy are already being sold through online sites. The market opportunity for the drug is huge in the world#39;s most populous country, where obesity rates are high especially among women. Illegal copycat versions of Wegovy are already being sold through online sites.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/novo-nordisk-india-head-eyes-2026-wegovy-launch-warns-against-copycats_17254981.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The market opportunity for the drug is huge in the world#39;s most populous country, where obesity rates are high especially among women. Illegal copycat versions of Wegovy are already being sold through online sites.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-79337","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2023\/200x200\/p\/pharma_capsule_tablet_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/79337","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=79337"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/79337\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=79337"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=79337"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=79337"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}